Skip to main content
close menu
close menu

Search UK HealthCare

Tomi Akinyemiju, PhD

Cancer Center Member

Research Programs:
Cancer Prevention and Control

College of Public Health, Department of Epidemiology

Faculty Rank:
Associate Professor

Research Focus

Dr. Akinyemiju's past research has examined racial disparities in breast cancer along the prevention continuum, highlighting the role of poverty and access to healthcare in cancer screening and survival.

More recently, her research focused on examining molecular biomarkers for cancer which can better predict prognosis and help to elucidate the underlying biological/genetic mechanisms underlying breast cancer etiology and outcomes. Given that metabolic syndrome is highly prevalent among US adults, especially among African-Americans, is adversely associated with breast cancer prognosis, and induces significant changes in expression of key cancer-related genes, her current work is focused on identifying unique metabolic syndrome-related genetic signatures in breast cancer tumors. These may be useful clinically for identifying patients at high risk of relapse who may benefit from additional treatment for metabolic syndrome, and/or inform the development of specific drug targets for genes altered due to metabolic syndrome.

Contact Information

CC449, Markey Cancer Center Roach Building
800 Rose Street
Lexington, KY 40536
United States